Bagsvaerd, Denmark

Wei Peng

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Novozymes A/s. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei Peng. Retrieved from https://idiyas.com/inventor/wei-peng-wk1o9lxf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Wei Peng in Polypeptide Technology

Introduction

Wei Peng is an accomplished inventor based in Bagsvaerd, Denmark. He has made significant contributions to the field of biotechnology, particularly in the area of polypeptides. His work has implications for various applications in research and industry.

Latest Patents

Wei Peng holds a patent related to polypeptides that exhibit hydrolytic activity. The invention encompasses polynucleotides that encode these polypeptides. Additionally, it includes nucleic acid constructs, vectors, and host cells that incorporate the polynucleotides. The methods of producing and utilizing these polypeptides are also covered in his patent, which highlights the innovative nature of his work. He has 1 patent to his name.

Career Highlights

Wei Peng is currently employed at Novozymes A/S, a leading company in the field of biotechnology. His role at Novozymes allows him to further explore and develop his innovative ideas in polypeptide technology. His contributions have been instrumental in advancing the company's research initiatives.

Collaborations

Wei Peng collaborates with talented colleagues, including Li Wang and Jesper Salomon. Their combined expertise fosters a productive environment for innovation and research.

Conclusion

Wei Peng's work in polypeptide technology exemplifies the impact of innovation in biotechnology. His patent and contributions at Novozymes A/S reflect his commitment to advancing scientific knowledge and applications in this vital field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…